CTMX -8% on ESMO data: https://globenewswire.com/news-release/2018/10/22/1624538/0/en/CytomX-Therapeutics-Presents-Clinical-Data-from-Probody-Platform-and-CX-072-at-2018-ESMO-Annual-Meeting.html